prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Patient: : Specimen # : Race: WHITE. AMENDED. SPECIMEN: A: RIGHT BREAST BIOPSY B: SENTINEL LYMPH NODE#1. C: SENTINEL LYMPH NODE#2. FINAL DIAGNOSIS: A. BREAST, RIGHT; EXCISION: - INFILTRATING DUCTAL CARCINOMA, POORLY DIFFERENTIATED (MODIFIED. BLOOM-RICHARDSON GRADE 9: MITOSES=3, NUCLEAR PLEOMORPHISM=3, TUBULE. FORMATION=3). -TUMOR SIZE 2.0 CM. - -TUMOR IS LESS THAN 0.1 CM FROM ANTERIOR AND MEDIAL SURGICAL MARGINS. - -ASSOCIATED FINDINGS: FIBROCYSTIC CHANGES INCLUDING STROMAL SCLEROSIS. AND MICROCYSTS. -MICROCALCIFICATIONS IDENTIFIED, ASSOCIATED WITH BENIGN BREAST TISSUE. - IMMUNOHISTOCHEMICAL STAINS FOR ESTROGEN AND PROGESTERONE AS FOLLOWS. ESTROGEN RECEPTOR: NEGATIVE. PROGESTERONE RECEPTOR: POSITIVE. -HER2/NEU (FISH METHODOLOGY) : NOT AMPLIFIED (1.3). B. LYMPH NODE, SENTINEL LYMPH NODE#1, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN IS APPROXIMATELY 0.5 CM IN SIZE. C. LYMPH NODE, SENTINEL LYMPH NODE#2, BIOPSY: -ONE (1) LYMPH NODE POSITIVE FOR METASTATIC CARCINOMA ON H AND E AND. IMMUNOHISTOLOGIC SECTIONS. -TUMOR SEEN LESS THAN 0.1 CM IN SIZE. COMMENT: This case is amended to reflect the review of. immunohistochemical stains for estrogen and progesterone receptors and. FISH for Her2/neu amplification. There is no change in diagnosis. COMMENT. ge 1. specimen #: FINAL DIAGNOSIS (continued) : Case amended. to report results of HER2 analysis by. immunohistochemistry (DAKO Hercep Test) : HER2/NEU PROTEIN OVEREXPRESSION: NEGATIVE (SCORE: 1+) . CLINICAL DIAGNOSIS AND HISTORY: -year-old female with palpable mass on right breast with no ultrasound. or mammographic correlation. GROSS DESCRIPTION: A. RIGHT BREAST BIOPSY received in formalin, labeled with the patient's. name, designated "RIGHT BREAST EXCISIONAL BIOPSY" is a lumpectomy specimen. measuring 10.2 x 7.0 x 3.0 cm in dimension. The specimen is composed. largely of yellow, lobulated, glistening adipose tissue admixed with white. fibrous areas. The specimen will be inked and oriented as follows: Black=deep, yellow=anterior, blue=medial, green=lateral, and red denotes. superficial and inferior. The specimen is serially sectioned from superior. to inferior revealing a fiarly well-defined, grey/tan nodule, 1.5 cm in. greatest dimension, abutting the anterior margin in the mid portion of the. specimen. Immediately adjacent to this nodule is a 1.5 cm patch of. indurated fibrous tissue involving the anterior and medial margins. The. remaining tissue consists of an admixture of fibrous tissue (approximately. 40%) and fat (approximately 60%) . The fibrous tissue is variably. indurated, particularly in the inferior half of the specimen. Sections of. nodule and fibrous tissue are harvested for the CBCP protocol. Matching. paraffin sections are as follows: A1: Nodule. A2: Indurated fibrous tissue adjacent to A1. A3: Fibrous tissue 3.0 cm inferior to nodule. A4: Fibrous tissue 6.0 cm inferior to nodule at the inferior margin. The remainder of the specimen is serially sectioned and submitted from. superior to inferior as follows: A5-A12: Representative section from each level from superior to inferior. Specimen #: GROSS DESCRIPTION (continued) : A13-A14: Next lower level. A15-A16: Next lower level. A17-A18 Inferior most section. B. SENTINEL LYMPH NODE#1 received in formalin, labeled with the patient'. name, designated "SUPERIOR LYMPH NODE NUMBER ONE" is a 1.7 x 1.3 x 0.8 cm. lymph node. A small portion of the node is harvested for the CBCP. protocol. The remaining tissue is entirely submitted in cassette B1. C. SENTINEL LYMPH NODE#2 received in formalin, labeled with the patient' S. name, designated "SENTINEL LYMPH NODE NUMBER TWO" is a 1.2 x 0.8 x 0.5 cm. tan/brown lymph node. The tissue is entirely submitted in cassette C1.

expanded version (tokens=1547) : 
 Histological classification: Infiltrating ductal carcinoma, poorly differentiated (modified Bloom-Richardson grade 9)

Subtype: Basal

Description of necrosis: Not mentioned

Tumor infiltrating lymphocytes: Not mentioned

Histological grade: Modified Bloom-Richardson grade 9

Nuclear grade: 3

Lymphovascular invasion: Not mentioned

Calcification: Microcalcifications identified, associated with benign breast tissue

Receptor status: Estrogen receptor negative, progesterone receptor positive

Ancillary testing results: HER2/neu (FISH methodology) not amplified, HER2/neu protein overexpression negative (score: 1+) 

Other findings: Fibrocystic changes including stromal sclerosis and microcysts

Metastatic carcinoma found in sentinel lymph nodes #1 and #2, with lymph node #1 having a larger metastasis (approximately 0.5 cm) compared to lymph node #2 (less than 0.1 cm).

Tumor size: 2.0 cm

Surgical margins: Tumor is less than 0.1 cm from anterior and medial surgical margins. 

Race: White

Clinical history:  Year-old female with palpable mass on right breast with no ultrasound or mammographic correlation. 

Gross description: Lumpectomy specimen measuring 10.2 x 7.0 x 3.0 cm in dimension. The specimen is composed largely of yellow, lob

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1702) : 
 The breast pathology report indicates poorly differentiated infiltrating ductal carcinoma, basal subtype, with a tumor size of 2.0 cm and metastatic carcinoma found in sentinel lymph nodes #1 and #2. HER2/neu protein overexpression was negative (score: 1+), estrogen receptor was negative, and progesterone receptor was positive. No lymphovascular invasion was noted but microcalcifications were identified with benign breast tissue. Surgically, the tumor is within 0.1 cm from anterior and medial surgical margins.

